vs

Side-by-side financial comparison of Canaan Inc. (CAN) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

Canaan Inc. is the larger business by last-quarter revenue ($20.8M vs $17.3M, roughly 1.2× Sol-Gel Technologies Ltd.). Sol-Gel Technologies Ltd. runs the higher net margin — 67.3% vs -18.4%, a 85.7% gap on every dollar of revenue.

Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

CAN vs SLGL — Head-to-Head

Bigger by revenue
CAN
CAN
1.2× larger
CAN
$20.8M
$17.3M
SLGL
Higher net margin
SLGL
SLGL
85.7% more per $
SLGL
67.3%
-18.4%
CAN

Income Statement — Q3 FY2025 vs Q2 FY2025

Metric
CAN
CAN
SLGL
SLGL
Revenue
$20.8M
$17.3M
Net Profit
$-3.8M
$11.6M
Gross Margin
99.9%
Operating Margin
-15.9%
65.1%
Net Margin
-18.4%
67.3%
Revenue YoY
217.7%
Net Profit YoY
487.6%
EPS (diluted)
$-0.05
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAN
CAN
SLGL
SLGL
Q4 25
$20.8M
Q3 25
$13.8M
Q2 25
$11.4M
$17.3M
Q3 24
$10.2M
Q2 24
$4.8M
$5.4M
Q2 23
$594.0K
Q2 22
$3.5M
Net Profit
CAN
CAN
SLGL
SLGL
Q4 25
$-3.8M
Q3 25
$-1.5M
Q2 25
$-11.9M
$11.6M
Q3 24
$-10.4M
Q2 24
$-5.4M
$2.0M
Q2 23
$-6.0M
Q2 22
$-134.0K
Gross Margin
CAN
CAN
SLGL
SLGL
Q4 25
99.9%
Q3 25
99.9%
Q2 25
99.9%
Q3 24
99.9%
Q2 24
99.8%
Q2 23
Q2 22
Operating Margin
CAN
CAN
SLGL
SLGL
Q4 25
-15.9%
Q3 25
-27.0%
Q2 25
-45.5%
65.1%
Q3 24
-77.2%
Q2 24
-193.9%
29.9%
Q2 23
-1098.8%
Q2 22
-13.2%
Net Margin
CAN
CAN
SLGL
SLGL
Q4 25
-18.4%
Q3 25
-11.0%
Q2 25
-104.4%
67.3%
Q3 24
-102.7%
Q2 24
-112.3%
36.4%
Q2 23
-1005.1%
Q2 22
-3.8%
EPS (diluted)
CAN
CAN
SLGL
SLGL
Q4 25
$-0.05
Q3 25
$-0.02
Q2 25
$-0.25
$4.17
Q3 24
Q2 24
$0.71
Q2 23
$-0.22
Q2 22
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAN
CAN
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$24.3M
Total DebtLower is stronger
$6.2M
Stockholders' EquityBook value
$52.4M
$31.9M
Total Assets
$92.5M
$39.3M
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAN
CAN
SLGL
SLGL
Q4 25
Q3 25
Q2 25
$24.3M
Q3 24
Q2 24
$26.5M
Q2 23
$33.5M
Q2 22
$15.6M
Total Debt
CAN
CAN
SLGL
SLGL
Q4 25
$6.2M
Q3 25
$6.2M
Q2 25
$6.2M
Q3 24
Q2 24
Q2 23
Q2 22
Stockholders' Equity
CAN
CAN
SLGL
SLGL
Q4 25
$52.4M
Q3 25
$44.7M
Q2 25
$33.8M
$31.9M
Q3 24
$43.6M
Q2 24
$56.8M
$34.9M
Q2 23
$48.3M
Q2 22
$50.4M
Total Assets
CAN
CAN
SLGL
SLGL
Q4 25
$92.5M
Q3 25
$81.7M
Q2 25
$78.0M
$39.3M
Q3 24
$69.3M
Q2 24
$73.7M
$42.0M
Q2 23
$55.1M
Q2 22
$55.0M
Debt / Equity
CAN
CAN
SLGL
SLGL
Q4 25
0.12×
Q3 25
0.14×
Q2 25
0.18×
Q3 24
Q2 24
Q2 23
Q2 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons